Characterization of the clinical features of five families with hereditary primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2.

The hereditary conditions of primary cutaneous lichen amyloidosis and multiple endocrine neoplasia type 2 (MEN 2) are rare clinical entities. The initial reports of two families in which the two conditions coincided have led to the identification of at least eight additional families with this clinical syndrome. In this report we describe the clinical features in five of these eight families. The salient feature in these five families is the presence of unilateral (46%) or bilateral (64%) pruritic and lichenoid skin lesions located over the upper portion of the back. Family members describe these skin lesions as intermittently intensely pruritic leading to scratching and excoriation of the upper back region. The presence of MEN 2 has been documented in 97% of family members with this skin lesion, the one exception being a child who is at risk for development of MEN 2A in whom the diagnosis has not yet been made. Of family members who have MEN 2A, 27% do not have an identifiable skin lesion, although the skin lesion developed in one patient two years after a curative thyroidectomy for medullary thyroid carcinoma (MTC). Four of the five families have members with pheochromocytoma; one with five affected members has only MTC. The finding of this clinical syndrome in geographically diverse portions of the world and the lack of overlap with MEN 2A without the skin lesion suggest it is a distinct clinical variant of MEN 2A.

[1]  H. Sobol,et al.  [Cutaneous lesion associated with multiple endocrine neoplasms type 2A (Sipple's syndrome). An early clinical marker]. , 1992, Presse medicale.

[2]  B. Kousseff,et al.  Sipple syndrome with lichen amyloidosis as a paracrinopathy: pleiotropy, heterogeneity, or a contiguous gene? , 1991, Journal of the American Academy of Dermatology.

[3]  M. Alsina,et al.  Primary localized cutaneous amyloidosis and familial medullary thyroid carcinoma , 1991, Clinical endocrinology.

[4]  T. Takenawa,et al.  Biochemical analysis of amyloid. , 1990, Clinics in dermatology.

[5]  I. Halperin,et al.  Cutaneous lichen amyloidosis and familial medullary thyroid carcinoma. , 1990, Annals of internal medicine.

[6]  J. Ollague,et al.  Epidemiology of primary cutaneous amyloidoses in South America. , 1990, Clinics in dermatology.

[7]  T. Tan Epidemiology of primary cutaneous amyloidoses in southeast Asia. , 1990, Clinics in dermatology.

[8]  B. Alford,et al.  Multiple endocrine neoplasia type 2a associated with cutaneous lichen amyloidosis. , 1989, Annals of internal medicine.

[9]  M. D'armiento,et al.  HEREDITARY LOCALIZED PRURITUS IN AFFECTED MEMBERS OF A KINDRED WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A (SIPPLE'S SYNDROME) , 1989, Clinical endocrinology.

[10]  Chrang-shi Lin,et al.  Friction Amyloidosis , 1988, International journal of dermatology.

[11]  A H Tashjian,et al.  The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. , 1988, The New England journal of medicine.

[12]  E. Massey,et al.  Localized pruritus-notalgia paresthetica. , 1979, Archives of dermatology.

[13]  O. Chabre,et al.  Cutaneous lesion associated with multiple endocrine neoplasia type 2A: lichen amyloidosis or notalgia paresthetica? , 1992, Henry Ford Hospital medical journal.

[14]  M. D'armiento,et al.  Cutaneous lichen amyloidosis associated with multiple endocrine neoplasia type 2A. , 1989, Henry Ford Hospital medical journal.